Emmaus Life Sciences, Inc. ( EMMA) - Stock Earnings
EMMA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 17, 2026, midnight | — / — | — | — / — | — |
EMMA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -3.5 million USD | 6.8 million USD |
| 2023Q2 | -1.5 million USD | 10.8 million USD |
| 2023Q3 | 67000 USD | 5.0 million USD |
EMMA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -15.9 million USD | 20.6 million USD |
| 2022 | -10.7 million USD | 18.4 million USD |
| 2023 | -4.7 million USD | 28.5 million USD |
| 2025 Est. | — | — |
EMMA
Price: $0.01
52 week price:
Earnings Per Share: -0.12 USD
P/E Ratio: -0.12
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 30500
Market Capitalization: 761543